Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics GlobeNewswire November 10, 2025 JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) — ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for diverse commercial applications, today […]

Seasoned global leader to expand customer relationships and drive revenue pipeline Sivers SemiconductorsAB(SIVE.ST),a global leader in photonics and wireless technologies, today announced the appointment of Raymond Biagan as its new Chief Revenue Officer (CRO), effective November 10, 2025. In this pivotal role, Raymond will be responsible for Global Sales and Field Applications Engineering. Raymond joins

Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR(1) by December 2025, Fastest Supplement Brand Growth in Industry History GlobeNewswire November 10, 2025 Total Revenue Surges 568% YoY to $23.6 million; IM8 Monthly Revenue Hits Record US$9 million in October; Bitcoin Treasury Reaches 387 BTC (~$40M); IM8 Projects $180 – $200M

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ:MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=176404&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

DENVER , Nov. 10, 2025 (GLOBE NEWSWIRE) — Wenlay today announced the launch of a new cross-chain bridge solution, aimed at addressing asset liquidity and cross-domain settlement issues in multi-chain ecosystems. Through its “Composable Settlement and Cross-Chain Bridge” module, the solution enables seamless transfer of assets and messages across chains, marking a significant step for

Wenlay Releases Cross-Chain Bridge Solution to Tackle Multi-Chain Liquidity Challenges GlobeNewswire November 10, 2025 DENVER , Nov. 10, 2025 (GLOBE NEWSWIRE) — Wenlay today announced the launch of a new cross-chain bridge solution, aimed at addressing asset liquidity and cross-domain settlement issues in multi-chain ecosystems. Through its “Composable Settlement and Cross-Chain Bridge” module, the solution

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dexcom-inc-lawsuit-submission-form-2?prid=176403&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Molina Healthcare, Inc. ("Molina Healthcare, Inc.") (NYSE:MOH) concerning possible violations of federal securities laws. On October 23, 2025, Molina published its third quarter, fiscal 2025 earnings well below consensus and slashed its

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / If you suffered a loss on your CarMax, Inc. (NYSE:KMX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/carmax-inc-lawsuit-submission-form?prid=176416&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / If you suffered a loss on your Fortinet, Inc. (NASDAQ:FTNT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fortinet-inc-lawsuit-submission-form?prid=176412&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call